HALO logo
halo search icon
Biogen Inc.

US$187.80

Price Change Indicator
-2.76 (-1.448%)
Biogen Inc.
BIIB · NAS

Biogen Inc.

Start Trading BIIB for Free

US$187.80

Price Arrow-2.76 (-1.448%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO 500HALO AllHALO Price MomentumHALO SmallHammer BearishHammer Bearish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Biogen Inc. Overview

BIIB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Weak

Garp

Neutral

Mqv Small

Weak

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Neutral

About BIIB

icon
icon

Telephone

1.617.679.2000

icon

Address

225 Binney Street, Cambridge, MA 02142

Description

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

BIIB Price Chart

Key Stats

Market Cap

US$28.13B

PE

20.00

EV/EBITDA

8.5

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 121.05 - 205.97

Trade Value (12mth)

US$61,939,452.00

1 week

-1.24%

1 month

2.48%

YTD

7.16%

1 year

50.26%

All time high

468.55

Key Fundamentals

EPS 3 yr Growth

-57.90%

EBITDA Margin

34.90%

Operating Cashflow

$2,205m

Free Cash Flow Return

9.50%

ROIC

5.60%

Interest Coverage

12.40

Quick Ratio

2.00

Other Data

Shares Outstanding (Fully Diluted)

148m

HALO Sector

Healthcare

Next Company Report Date

17-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

BIIB Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
12 May 26
07 May 26
29 April 26

BIIB Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock8.0211.218.83locklocklock
EPS (Fully Diluted)
 $locklocklocklock7.9711.198.79locklocklock
Growth
 %locklocklocklock-61.739.7-21.3locklocklock
PE
 Xlocklocklocklock32.413.720locklocklock
EV/EBITDA
 Xlocklocklocklock20.59.48.5locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Biogen Inc. (BIIB:NAS)?
Halo FAQ
The current share price of Biogen Inc. (BIIB:NAS) is USD$187.80.
What is the 52-week high share price for Biogen Inc. (BIIB:NAS)?
Halo FAQ
The 52-week high share price for Biogen Inc. (BIIB:NAS) is USD$205.97.
What is the 52-week low share price for Biogen Inc. (BIIB:NAS)?
Halo FAQ
The 52-week low share price for Biogen Inc. (BIIB:NAS) is USD$121.05.
What is the dividend yield for Biogen Inc. (BIIB:NAS)?
Halo FAQ
Biogen Inc. (BIIB:NAS) does not pay a dividend.
What was Biogen Inc. (BIIB:NAS) last dividend payment?
Halo FAQ
Biogen Inc. (BIIB:NAS) does not pay a dividend.
What is the franking level for Biogen Inc. (BIIB:NAS)?
Halo FAQ
Biogen Inc. (BIIB:NAS) has a franking level of 0.00%.
In which sector is Biogen Inc. (BIIB:NAS) classified?
Halo FAQ
Biogen Inc. (BIIB:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Biogen Inc. (BIIB:NAS)?
Halo FAQ
The current P/E ratio for Biogen Inc. (BIIB:NAS) is 20.00.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial